E-LIB Suche - Ergebnisse für: Bomhof, Charlotte

1

Whole genome sequencing as a ticket to cancer treatment in ..:

Smids, Jilles ; Bomhof, Charlotte ; IJzerman, Maarten.
Journal of Cancer Policy. 41 (2024) - p. 100492 , 2024

Link: https://doi.org/10.1016/..

2

Ethics of access to newly approved expensive medical treatm..:

Bomhof, Charlotte H. C. ; Smids, Jilles ; Sybesma, Sybren..
Frontiers in Pharmacology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

3

Physicians' Perspectives on Ethical Issues Regarding Expens..:

Bomhof, Charlotte H. C. ; Schermer, Maartje ; Sleijfer, Stefan.
AJOB Empirical Bioethics. 13 (2022) 4 - p. 275-286 , 2022

Link: https://doi.org/10.1080/..

4

The Impact of Incidental Findings Detected During Brain Ima..:

BOMHOF, CHARLOTTE H.C. ; VAN BODEGOM, LISA ; VERNOOIJ, MEIKE W....
Cambridge Quarterly of Healthcare Ethics. 29 (2020) 4 - p. 542-556 , 2020

Link: https://doi.org/10.1017/..

5

The Impact of Incidental Findings Detected During Brain Ima..:

Bomhof, Charlotte ; Van Bodegom, L ; Vernooij, Meike...
Bomhof , C , Van Bodegom , L , Vernooij , M , Pinxten , W , Beaufort , I & Bunnik , E M 2020 , ' The Impact of Incidental Findings Detected During Brain Imaging on Research Participants of the Rotterdam Study: An Interview Study ' , Cambridge Quarterly of Healthcare Ethics , vol. 29 , no. 4 , Pii s096318012000030 , pp. 542-556 . https://doi.org/10.1017/s0963180120000304. , 2020

Link: https://pure.eur.nl/en/p..

6

Table2_Ethics of access to newly approved expensive medical..:

Charlotte H. C. Bomhof ; Jilles Smids ; Sybren Sybesma..
doi:10.3389/fphar.2023.1265029.s002. , 2024

Link: https://doi.org/10.3389/..

7

Table3_Ethics of access to newly approved expensive medical..:

Charlotte H. C. Bomhof ; Jilles Smids ; Sybren Sybesma..
doi:10.3389/fphar.2023.1265029.s003. , 2024

Link: https://doi.org/10.3389/..

8

Table2_Ethics of access to newly approved expensive medical..:

Charlotte H. C. Bomhof ; Jilles Smids ; Sybren Sybesma..
doi:10.3389/fphar.2023.1265029.s002. , 2024

Link: https://doi.org/10.3389/..

9

Table3_Ethics of access to newly approved expensive medical..:

Charlotte H. C. Bomhof ; Jilles Smids ; Sybren Sybesma..
doi:10.3389/fphar.2023.1265029.s003. , 2024

Link: https://doi.org/10.3389/..

10

Table1_Ethics of access to newly approved expensive medical..:

Charlotte H. C. Bomhof ; Jilles Smids ; Sybren Sybesma..
doi:10.3389/fphar.2023.1265029.s001. , 2024

Link: https://doi.org/10.3389/..

11

Table2_Ethics of access to newly approved expensive medical..:

Charlotte H. C. Bomhof ; Jilles Smids ; Sybren Sybesma..
doi:10.3389/fphar.2023.1265029.s002. , 2024

Link: https://doi.org/10.3389/..

12

Table3_Ethics of access to newly approved expensive medical..:

Charlotte H. C. Bomhof ; Jilles Smids ; Sybren Sybesma..
doi:10.3389/fphar.2023.1265029.s003. , 2024

Link: https://doi.org/10.3389/..

13

Table1_Ethics of access to newly approved expensive medical..:

Charlotte H. C. Bomhof ; Jilles Smids ; Sybren Sybesma..
doi:10.3389/fphar.2023.1265029.s001. , 2024

Link: https://doi.org/10.3389/..

14

Table1_Ethics of access to newly approved expensive medical..:

Charlotte H. C. Bomhof ; Jilles Smids ; Sybren Sybesma..
doi:10.3389/fphar.2023.1265029.s001. , 2024

Link: https://doi.org/10.3389/..